Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical TrialsEllen M. Apperloo, Hiddo J.L. Heerspink, Andrea Hemmingway et al.|Diabetes Care|2025Cited by 42
<b>Tirzepatide Associated with Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials</b>Ellen M. Apperloo, Hiddo J.L. Heerspink, Naveed Sattar et al.|Unknown|2025Cited by 0
<b>Tirzepatide Associated with Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials</b>Ellen M. Apperloo, Hiddo J.L. Heerspink, Katherine R. Tuttle et al.|Unknown|2025Cited by 0